0888-0018
1.2
否
不在预警名单内
否
Q3区
1986
Bimonthly
医学
UNITED STATES
Informa Healthcare
SCIE,Scopus
63
3.15
-
PHO: Pediatric Hematology and Oncology covers all aspects of research and patient management within the area of blood disorders and malignant diseases of childhood. Our goal is to make PHO: Pediatric Hematology and Oncology the premier journal for the international community of clinicians and scientists who together aim to define optimal therapeutic strategies for children and young adults with cancer and blood disorders. The journal supports articles that address research in diverse clinical settings, exceptional case studies/series that add novel insights into pathogenesis and/or clinical care, and reviews highlighting discoveries and challenges emerging from consortia and conferences. Clinical studies as well as basic and translational research reports regarding cancer pathogenesis, genetics, molecular diagnostics, pharmacology, stem cells, molecular targeting, cellular and immune therapies and transplantation are of interest. Papers with a focus on supportive care, late effects and on related ethical, legal, psychological, social, cultural, or historical aspects of these fields are also appreciated. Reviews on important developments in the field are welcome. Articles from scientists and clinicians across the international community of Pediatric Hematology and Oncology are considered for publication. The journal is not dependent on or connected with any organization or society. All submissions undergo rigorous peer review prior to publication. Our Editorial Board includes experts in Pediatric Hematology and Oncology representing a wide range of academic and geographic diversity.
PHO:小儿血液学和肿瘤学涵盖血液疾病和儿童恶性疾病领域内研究和患者管理的所有方面。我们的目标是使 PHO:儿科血液学和肿瘤学成为国际临床医生和科学家社区的首要期刊,他们共同致力于为患有癌症和血液疾病的儿童和年轻人制定最佳治疗策略。该杂志支持涉及不同临床环境研究的文章、对发病机制和/或临床护理增加新见解的特殊案例研究/系列,以及强调联盟和会议中出现的发现和挑战的评论。有关癌症发病机制、遗传学、分子诊断学、药理学、干细胞、分子靶向、细胞和免疫疗法以及移植的临床研究以及基础和转化研究报告值得关注。关注支持性护理、后期影响以及这些领域的相关伦理、法律、心理、社会、文化或历史方面的论文也很受欢迎。欢迎对该领域的重要发展发表评论。来自国际儿科血液学和肿瘤学界的科学家和临床医生的文章正在考虑发表。本刊不依赖或与任何组织或社团有联系。所有提交的内容在发布前都经过严格的同行评审。我们的编辑委员会包括儿科血液学和肿瘤学方面的专家,代表了广泛的学术和地域多样性。
《PEDIATRIC HEMATOLOGY AND ONCOLOGY》期刊已被查看: 次
如果你是第一次发表SCI的话,我还是建议你啊,花钱找一个好的老师,一呢是让你尽快拿到一个结果,有一个好的开始啊,二是为了摸清套路,也对自己未来的科研路呢,能起到
JCR:Q2区--分类:医学
影响因子2.8
收录SCIE,Scopus,ssci
JCR:Q4区--分类:医学
影响因子0.6
收录SCIE,Scopus,DOAJ开放期刊
JCR:Q2区--分类:医学
影响因子1.8
收录SCIE,Scopus
JCR:Q1区--分类:医学
影响因子4.7
收录SCIE,Scopus
JCR:Q1区--分类:医学
影响因子3.4
收录SCIE,Scopus,ssci
JCR:Q4区--分类:医学
影响因子1.1
收录SCIE,Scopus
JCR:Q4区--分类:医学
影响因子0.4
收录SCIE,Scopus
JCR:Q4区--分类:医学
影响因子0.9
收录SCIE,Scopus